Royce & Associates’s Diebold Nixdorf DBD Stock Holding History
Bought
Maintained
Sold
Other funds holding DBD
MCM
Royce & Associates's DBD Position: Q2 2026 in Review
Royce & Associates reduced its Diebold Nixdorf (DBD) stake by 1.5% in Q2 2026, selling an estimated $207K and leaving 164,965 shares worth $14M. The position accounts for 0.11% of the portfolio, ranked #303.
Royce & Associates first reported a position in DBD in Q3 2024 and has held it in 8 quarters since. 216 funds tracked by Wall St. Rank hold DBD as of Q2 2026.
- Royce & Associates held 164,965 shares of Diebold Nixdorf worth $14M as of Q2 2026.
- Royce & Associates sold 2,578 Diebold Nixdorf shares in Q2 2026, an estimated $207K.
- Diebold Nixdorf made up 0.11% of Royce & Associates's portfolio in Q2 2026, its #303 holding.
- Royce & Associates first reported a position in Diebold Nixdorf in Q3 2024 and has held it in 8 quarters since.
- 216 funds tracked by Wall St. Rank held Diebold Nixdorf as of Q2 2026.
Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.